Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.62
-0.15 (-2.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 | Buy | Maintains | $19 | +187.01% | Oct 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $17 | Buy | Maintains | $17 | +156.80% | Oct 1, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $14 | Buy | Maintains | $14 | +111.48% | Oct 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +66.16% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +141.69% | Sep 30, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $25 | Buy | Reiterates | $25 | +277.64% | Sep 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 | Buy | Maintains | $17 | +156.80% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.